Advertisement
U.S. markets open in 2 hours 40 minutes

Gerresheimer AG (GXI.DE)

XETRA - XETRA Delayed Price. Currency in EUR
104.80+1.10 (+1.06%)
As of 11:35AM CET. Market open.

Gerresheimer AG

Klaus-Bungert-Strasse 4
Düsseldorf 40468
Germany
49 211 61 81 00
https://www.gerresheimer.com

Sector(s)Healthcare
IndustryMedical Instruments & Supplies
Full Time Employees11,660

Key Executives

NameTitlePayExercisedYear Born
Mr. Dietmar SiemssenCEO, Chairman of the Management Board and CEO of Plastics, Devices & Advanced Technologies Division2.17MN/A1963
Dr. Bernd Metzner Ph.D.CFO & Member of the Management Board1.31MN/A1970
Dr. Lukas BurkhardtMember of the Management Board1.28MN/A1979
Ms. Katja SchnitzlerGlobal Senior VP of People & Organization and Member of Supervisory Board108kN/A1981
Mr. Guido PickertHead of Investor RelationsN/AN/AN/A
Ueli UtzingerGroup Senior Director Marketing & CommunicationN/AN/AN/A
Ms. Carolin NadiloCorporate Director of Investor RelationsN/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in EUR.

Description

Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services. It also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, the company offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. It offers its products to pharmacy chains, supermarkets, and wholesalers. The company serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Corporate Governance

Gerresheimer AG’s ISS Governance QualityScore as of March 1, 2024 is 4. The pillar scores are Audit: 5; Board: 5; Shareholder Rights: 1; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.